| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2005;36:533.)
© 2005 American Heart Association, Inc.
Original Contributions |
From Clinica Neurologica (A.P., E.D.Z., R.S., V.V., A.P.), Università degli Studi di Brescia, Brescia, Italia; the Dipartimento di Scienze Sanitarie Applicate (M.G.), Sezione di Statistica Medica ed Epidemiologia, Università degli Studi di Pavia, Pavia, Italia; III Laboratorio di Analisi (S.A.), Biotecnologie, Università degli Studi di Brescia, Brescia, Italia; the Dipartimento di Scienze Mediche e Chirurgiche (D.A.), Università degli Studi di Brescia, Brescia, Italia; and the Dipartimento di Biochimica (L.C.), Università degli Studi di Brescia, Brescia, Italia.
Correspondence to Dr Alessandro Pezzini, Clinica Neurologica, Università degli Studi di Brescia, P.le Spedali Civili, 1, 25100 Brescia, Italia. E-mail ale_pezzini{at}hotmail.com
Background and Purpose Combinations of multiple predisposing polymorphisms and their interactions with modifiable factors may result in synergistic effects on the risk of ischemic stroke. These mechanisms are more likely to play a relevant role in younger individuals.
Methods The cumulative effect of the 20210A variant of prothrombin gene, the 1691A variant of factor V gene, the TT677 genotype of the methylenetetrahydrofolate reductase (MTHFR) gene, and the
4-carriership of the apolipoprotein (APOE) gene, as well as their interactions with modifiable predisposing factors, were determined in a series of 163 stroke patients aged younger than 45 years and 158 controls.
Results Odds ratios (ORs) for stroke were 1.73 (95% confidence interval [CI], 1.20 to 2.51) in subjects with 1 polymorphism and 3.00 (95% CI, 1.43 to 6.30) in those with
2. Compared with nonsmokers with none of the studied polymorphisms, ORs for stroke were 1.88 (95% CI, 1.18 to 3.00) and 3.55 (95% CI, 1.40 to 8.98) for nonsmokers with 1 and 2 polymorphisms, respectively, and 3.99 (95% CI, 2.00 to 7.96) and 15.99 (95% CI, 4.01 to 63.3) for smokers. Compared with nonhypertensive subjects bearing no polymorphisms, ORs were 1.91 (95% CI, 1.28 to 2.87) and 3.68 (95% CI, 1.64 to 8.26) for nonhypertensive subjects with 1 and 2 polymorphisms, 3.28 (95% CI, 1.01 to 10.7) and 10.79 (95% CI, 1.01 to 115.4) for hypertensive.
Conclusions These data suggest a genedose effect of the examined prothrombotic and proatherogenic gene variants and a synergistic effect of these polymorphisms and modifiable risk factors in the pathogenesis of cerebral ischemia in young adults.
Key Words: genetics risk factors stroke, ischemic
This article has been cited by other articles:
![]() |
A. Pezzini, M. Grassi, E. Del Zotto, C. Lodigiani, P. Ferrazzi, A. Spalloni, R. Patella, A. Giossi, I. Volonghi, L. Iacoviello, et al. Common genetic markers and prediction of recurrent events after ischemic stroke in young adults Neurology, September 1, 2009; 73(9): 717 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Djordjevic, M. Stankovic, V. Brankovic-Sreckovic, L. Rakicevic, and D. Radojkovic Genetic Risk Factors for Arterial Ischemic Stroke in Children: A Possible MTHFR and eNOS Gene-Gene Interplay? J Child Neurol, July 1, 2009; 24(7): 823 - 827. [Abstract] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |